- 专利标题： Derivatisation of erythropoietin (EPO)
-
申请号： US14313888申请日： 2014-06-24
-
公开(公告)号： US09266936B2公开(公告)日： 2016-02-23
- 发明人: Sanjay Jain , Peter Laing , Gregory Gregoriadis , Norbert Oskar Rumpf
- 申请人： Lipoxen Technologies Limited
- 申请人地址： GB London
- 专利权人： Lipoxen Technologies Limited
- 当前专利权人： Lipoxen Technologies Limited
- 当前专利权人地址： GB London
- 代理机构： One3 IP Management, P.C.
- 代理商 Dean G. Stathakis; Peter D. Weinstein
- 优先权： EP06117830 20060725
- 主分类号： A61K38/00
- IPC分类号： A61K38/00 ; A61K38/18 ; C07K14/535 ; A61K47/48 ; C07K14/52 ; C07K14/505 ; C07K14/575 ; A61K38/46 ; A61K38/19
摘要：
The present invention relates to a compound which is a polysaccharide derivative of EPO, or of an EPO like protein, wherein the polysaccharide is anionic and comprises between 2 and 200 saccharide units. The present invention also relates to pharmaceutical compositions comprising the novel compounds, and methods for making the novel compounds.
公开/授权文献
- US20140309166A1 Derivatisation of Erythropoietin (EPO) 公开/授权日：2014-10-16